Iovance Biotherapeutics, Inc. (IOVA) NASDAQ

2.39

+0.035(+1.49%)

Updated at January 14 11:10AM

Currency In USD

Valuation

Market Cap2.15B
Enterprise Value2.09B
P/E Ratio-2.2
PEG Ratio-0.9
Price/Sales Ratio3.18
Price/Book Ratio1.24
Enterprise/Revenue2.76
Enterprise/EBITDA-1.87

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-1.59
Operating Margin-1.66

Management Effectiveness

Return On Assets-0.44
Return On Equity-0.55

Income Statement

Revenue164.07M
Revenue/Share0.69
Gross Profit40.08M
EBITDA-351.67M
Net Income-372.18M
Diluted EPS-1.28

Balance Sheet

Total Cash300.8M
Total Cash/Share0.83
Total Debt52.49M
Total Debt/Equity0.07
Current Ratio3.41
Book Value Per Share1.93

Price History

52-Week Change-59.27
52-Week High6.5
52-Week Low1.64
Moving Average 50 Days2.4
Moving Average 200 Days2.4

Statistics

Average Volume14.52M
Shares Outstanding331.69M
% Held by Institutions63.66

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:100
Last Split DateSeptember 26, 2013